Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical and Experimental Dermatology|October 19, 2024
Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Kerry Williams, Georgia Lada, Nick J Reynolds, et al.
Oncogene|May 4, 2018
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma gradesNingning Li, Ying Zhang, Kastytis Sidlauskas, et al.
The Journal of Investigative Dermatology|October 30, 2017
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Ireny Y K Iskandar, Richard B Warren, Mark Lunt, et al.
Clinical and Experimental Dermatology|May 22, 2025
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohortOras A Alabas, Ian Evans, Kathleen Mcelhone, et al.
Frontiers in Cell and Developmental Biology|September 9, 2021
PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair PathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Frontiers in Cell and Developmental Biology|September 15, 2025
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Nature|July 3, 2024
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistanceHengxing Chen, Yun Li, Huafu Li, et al.
Cellular and Molecular Life Sciences : CMLS|February 18, 2022
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stabilityHuafu Li, Chunming Wang, Linxiang Lan, et al.
The British Journal of Dermatology|November 6, 2023
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategiesAbhishek Abhishek, Matthew D Stevenson, Georgina Nakafero, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
Pageof 3